Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study

Takaya Ozeki, Masahiko Ando, Makoto Yamaguchi, Takayuki Katsuno, Sawako Kato, Yoshinari Yasuda, Naotake Tsuboi and Shoichi Maruyama

PLOS ONE, 2018, vol. 13, issue 6, 1-14

Abstract: Background: In patients with adult minimal change disease (MCD), proteinuria relapse is a problem to solve. However, the optimal relapse treatment regimen remains unclear regarding steroid dose. We described the treatment pattern of adult MCD patients and evaluated the appropriate steroid dose for relapse treatment. Methods: This retrospective multicenter cohort study included 192 patients with adult biopsy-proven MCD from 14 hospitals in Japan. The prescription pattern of immunosuppressive drugs in relapse was reviewed. To assess the association between steroid dose used for relapse and subsequent outcomes, data of patients with tapered prednisolone (PSL) dosage to 20 mg/day) was not associated with favorable outcomes after the first relapse as compared to lower dose (10–20 mg/day).

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199228 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 99228&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0199228

DOI: 10.1371/journal.pone.0199228

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().